Hematology and Hemotherapy Department, Hospital Universitario Son Espases, IDISBA, 07120 Palma de Mallorca, Spain.
Molecular Biology Laboratory, Pathology Department, Hospital del Mar, 08003 Barcelona, Spain.
Genes (Basel). 2022 Sep 20;13(10):1686. doi: 10.3390/genes13101686.
Primary familial and congenital polycythemia is a rare disease characterized by an increase in red cell mass that may be due to pathogenic variants in the EPO receptor () gene. To date, 33 genetic variants have been reported to be associated. We analyzed the presence of variants in two patients with polycythemia in whom pathogenic variants had been previously discarded. Molecular analysis of the gene was performed by Sanger sequencing of the coding regions and exon/intron boundaries of exon 8. We performed in vitro culture of erythroid progenitor cells. Segregation studies were done whenever possible. The two patients studied showed hypersensitivity to EPO in in vitro cultures. Analysis of the gene unveiled two novel pathogenic variants. Genetic testing of asymptomatic relatives could guarantee surveillance and proper management.
原发性家族性和先天性红细胞增多症是一种罕见疾病,其特征是红细胞数量增加,这可能是由于促红细胞生成素受体()基因的致病变体引起的。迄今为止,已经报道了 33 种与该疾病相关的遗传变异。我们分析了两名红细胞增多症患者中 变异的存在情况,此前已排除了这两名患者的致病性变异。通过对 8 号外显子的编码区域和外显子/内含子边界进行 Sanger 测序,对 基因进行了分子分析。我们进行了红细胞祖细胞的体外培养。只要有可能,就进行分离研究。所研究的两名患者在体外培养中表现出对 EPO 的超敏反应。对 基因的分析揭示了两种新的致病性变异。对无症状亲属进行基因检测可以保证监测和适当的管理。